APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cognitive Behavioral Therapy for Insomnia

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Cognitive Behavioral Therapy for Insomnia Market Outlook and Growth Opportunities 2026

4 July 2026195 pages

Choose your research edition.

Industry ResearchCognitive Behavioral Therapy for Insomnia Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Cognitive Behavioral Therapy for Insomnia Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Cognitive Behavioral Therapy for Insomnia Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cognitive Behavioral Therapy for Insomnia Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Cognitive Behavioral Therapy for Insomnia Market Analysis and Forecast 2026-2032173 pages · $4,950 USD

Market perspective

The global Cognitive Behavioral Therapy for Insomnia market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Cognitive Behavioral Therapy for Insomnia is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cognitive Behavioral Therapy for Insomnia is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cognitive Behavioral Therapy for Insomnia is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Cognitive Behavioral Therapy for Insomnia market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Cognitive Behavioral Therapy for Insomnia market include MINERVA NEUROSCIENCES INC, CURRAX PHARMACEUTICALS LLC, Pfizer Inc., Sanofi, zydus cadila, Vanda Pharmaceuticals Inc., EISAI,, merck kgaa and darmstadt, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Cognitive Behavioral Therapy for Insomnia market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cognitive Behavioral Therapy for Insomnia and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cognitive Behavioral Therapy for Insomnia revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Cognitive Behavioral Therapy for Insomnia market.

Cognitive Behavioral Therapy for Insomnia Segment by Company

MINERVA NEUROSCIENCES INC

CURRAX PHARMACEUTICALS LLC

Pfizer Inc.

Sanofi

zydus cadila

Vanda Pharmaceuticals Inc.

EISAI,

merck kgaa

darmstadt

germany

VIATRIS INC

Takeda Pharmaceutical Company

Cognitive Behavioral Therapy for Insomnia Segment by Type

Non Pharmacological Therapy

Pharmacological Therapy

Cognitive Behavioral Therapy for Insomnia Segment by Application

Mental Health Services

Sleep Clinics

Pharmaceutical Industry

Sleep-related Devices and Technology

Cognitive Behavioral Therapy for Insomnia Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Cognitive Behavioral Therapy for Insomnia status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Cognitive Behavioral Therapy for Insomnia key companies, revenue, market share, and recent developments.

3. To split the Cognitive Behavioral Therapy for Insomnia breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Cognitive Behavioral Therapy for Insomnia market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cognitive Behavioral Therapy for Insomnia significant trends, drivers, influence factors in global and regions.

6. To analyze Cognitive Behavioral Therapy for Insomnia competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cognitive Behavioral Therapy for Insomnia market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cognitive Behavioral Therapy for Insomnia and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cognitive Behavioral Therapy for Insomnia.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cognitive Behavioral Therapy for Insomnia industry.

Chapter 3: Detailed analysis of Cognitive Behavioral Therapy for Insomnia company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Cognitive Behavioral Therapy for Insomnia in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Cognitive Behavioral Therapy for Insomnia in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cognitive Behavioral Therapy for Insomnia Industry Trends Table 2. Cognitive Behavioral Therapy for Insomnia Industry Drivers Table 3. Cognitive Behavioral Therapy for Insomnia Industry Opportunities and Challenges Table 4. Cognitive Behavioral Therapy for Insomnia Industry Restraints Table 5. Global Cognitive Behavioral Therapy for Insomnia Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cognitive Behavioral Therapy for Insomnia Revenue Share by Company (2021-2026) Table 7. Global Cognitive Behavioral Therapy for Insomnia Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Cognitive Behavioral Therapy for Insomnia Key Company Manufacturing Base & Headquarters Table 9. Global Cognitive Behavioral Therapy for Insomnia Company, Product Type & Application Table 10. Global Cognitive Behavioral Therapy for Insomnia Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Cognitive Behavioral Therapy for Insomnia by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Non Pharmacological Therapy Table 15. Significant Companies of Pharmacological Therapy Table 16. Global Cognitive Behavioral Therapy for Insomnia Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Cognitive Behavioral Therapy for Insomnia Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Cognitive Behavioral Therapy for Insomnia Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type (2021-2026) Table 20. Global Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Mental Health Services Table 22. Significant Companies of Sleep Clinics Table 23. Significant Companies of Pharmaceutical Industry Table 24. Significant Companies of Sleep-related Devices and Technology Table 25. Global Cognitive Behavioral Therapy for Insomnia Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Cognitive Behavioral Therapy for Insomnia Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Cognitive Behavioral Therapy for Insomnia Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application (2021-2026) Table 29. Global Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application (2027-2032) Table 30. Global Cognitive Behavioral Therapy for Insomnia Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Cognitive Behavioral Therapy for Insomnia Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Cognitive Behavioral Therapy for Insomnia Sales Value Share by Region (2021-2026) Table 33. Global Cognitive Behavioral Therapy for Insomnia Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Cognitive Behavioral Therapy for Insomnia Sales Value Share by Region (2027-2032) Table 35. Global Cognitive Behavioral Therapy for Insomnia Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Cognitive Behavioral Therapy for Insomnia Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Cognitive Behavioral Therapy for Insomnia Sales Value Market Share by Country (2021-2026) Table 38. Global Cognitive Behavioral Therapy for Insomnia Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Cognitive Behavioral Therapy for Insomnia Sales Value Market Share by Country (2027-2032) Table 40. MINERVA NEUROSCIENCES INC Company Information Table 41. MINERVA NEUROSCIENCES INC Business Overview Table 42. MINERVA NEUROSCIENCES INC Cognitive Behavioral Therapy for Insomnia Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. MINERVA NEUROSCIENCES INC Cognitive Behavioral Therapy for Insomnia Product Portfolio Table 44. MINERVA NEUROSCIENCES INC Recent Development Table 45. CURRAX PHARMACEUTICALS LLC Company Information Table 46. CURRAX PHARMACEUTICALS LLC Business Overview Table 47. CURRAX PHARMACEUTICALS LLC Cognitive Behavioral Therapy for Insomnia Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. CURRAX PHARMACEUTICALS LLC Cognitive Behavioral Therapy for Insomnia Product Portfolio Table 49. CURRAX PHARMACEUTICALS LLC Recent Development Table 50. Pfizer Inc. Company Information Table 51. Pfizer Inc. Business Overview Table 52. Pfizer Inc. Cognitive Behavioral Therapy for Insomnia Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Pfizer Inc. Cognitive Behavioral Therapy for Insomnia Product Portfolio Table 54. Pfizer Inc. Recent Development Table 55. Sanofi Company Information Table 56. Sanofi Business Overview Table 57. Sanofi Cognitive Behavioral Therapy for Insomnia Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Sanofi Cognitive Behavioral Therapy for Insomnia Product Portfolio Table 59. Sanofi Recent Development Table 60. zydus cadila Company Information Table 61. zydus cadila Business Overview Table 62. zydus cadila Cognitive Behavioral Therapy for Insomnia Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. zydus cadila Cognitive Behavioral Therapy for Insomnia Product Portfolio Table 64. zydus cadila Recent Development Table 65. Vanda Pharmaceuticals Inc. Company Information Table 66. Vanda Pharmaceuticals Inc. Business Overview Table 67. Vanda Pharmaceuticals Inc. Cognitive Behavioral Therapy for Insomnia Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Vanda Pharmaceuticals Inc. Cognitive Behavioral Therapy for Insomnia Product Portfolio Table 69. Vanda Pharmaceuticals Inc. Recent Development Table 70. EISAI, Company Information Table 71. EISAI, Business Overview Table 72. EISAI, Cognitive Behavioral Therapy for Insomnia Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. EISAI, Cognitive Behavioral Therapy for Insomnia Product Portfolio Table 74. EISAI, Recent Development Table 75. merck kgaa Company Information Table 76. merck kgaa Business Overview Table 77. merck kgaa Cognitive Behavioral Therapy for Insomnia Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. merck kgaa Cognitive Behavioral Therapy for Insomnia Product Portfolio Table 79. merck kgaa Recent Development Table 80. darmstadt Company Information Table 81. darmstadt Business Overview Table 82. darmstadt Cognitive Behavioral Therapy for Insomnia Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. darmstadt Cognitive Behavioral Therapy for Insomnia Product Portfolio Table 84. darmstadt Recent Development Table 85. germany Company Information Table 86. germany Business Overview Table 87. germany Cognitive Behavioral Therapy for Insomnia Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. germany Cognitive Behavioral Therapy for Insomnia Product Portfolio Table 89. germany Recent Development Table 90. VIATRIS INC Company Information Table 91. VIATRIS INC Business Overview Table 92. VIATRIS INC Cognitive Behavioral Therapy for Insomnia Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. VIATRIS INC Cognitive Behavioral Therapy for Insomnia Product Portfolio Table 94. VIATRIS INC Recent Development Table 95. Takeda Pharmaceutical Company Company Information Table 96. Takeda Pharmaceutical Company Business Overview Table 97. Takeda Pharmaceutical Company Cognitive Behavioral Therapy for Insomnia Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Takeda Pharmaceutical Company Cognitive Behavioral Therapy for Insomnia Product Portfolio Table 99. Takeda Pharmaceutical Company Recent Development Table 100. Research Programs/Design for This Report Table 101. Authors List of This Report Table 102. Secondary Sources Table 103. Primary Sources List of Figures Figure 1. Cognitive Behavioral Therapy for Insomnia Product Image Figure 2. Global Cognitive Behavioral Therapy for Insomnia Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cognitive Behavioral Therapy for Insomnia Market Size (2021-2032) & (US$ Million) Figure 4. Global Cognitive Behavioral Therapy for Insomnia Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Non Pharmacological Therapy Image Figure 8. Pharmacological Therapy Image Figure 9. Global Cognitive Behavioral Therapy for Insomnia Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Cognitive Behavioral Therapy for Insomnia Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type (2021-2032) Figure 12. Mental Health Services Image Figure 13. Sleep Clinics Image Figure 14. Pharmaceutical Industry Image Figure 15. Sleep-related Devices and Technology Image Figure 16. Global Cognitive Behavioral Therapy for Insomnia Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Cognitive Behavioral Therapy for Insomnia Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application (2021-2032) Figure 19. Global Cognitive Behavioral Therapy for Insomnia Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Cognitive Behavioral Therapy for Insomnia Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Cognitive Behavioral Therapy for Insomnia Sales Value (2021-2032) & (US$ Million) Figure 22. North America Cognitive Behavioral Therapy for Insomnia Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Cognitive Behavioral Therapy for Insomnia Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Cognitive Behavioral Therapy for Insomnia Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Cognitive Behavioral Therapy for Insomnia Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Cognitive Behavioral Therapy for Insomnia Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Cognitive Behavioral Therapy for Insomnia Sales Value (2021-2032) & (US$ Million) Figure 28. South America Cognitive Behavioral Therapy for Insomnia Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Cognitive Behavioral Therapy for Insomnia Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Cognitive Behavioral Therapy for Insomnia Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Non Pharmacological Therapy
  • Pharmacological Therapy
Applications
  • Mental Health Services
  • Sleep Clinics
  • Pharmaceutical Industry
  • Sleep-related Devices and Technology
Companies covered
  • MINERVA NEUROSCIENCES INC
  • CURRAX PHARMACEUTICALS LLC
  • Pfizer Inc.
  • Sanofi
  • zydus cadila
  • Vanda Pharmaceuticals Inc.
  • EISAI,
  • merck kgaa
  • darmstadt
  • germany
  • VIATRIS INC
  • Takeda Pharmaceutical Company

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cognitive Behavioral Therapy for Insomnia Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cognitive Behavioral Therapy for Insomnia Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Cognitive Behavioral Therapy for Insomnia Market Dynamics
  1. 2.1 Cognitive Behavioral Therapy for Insomnia Industry Trends
  2. 2.2 Cognitive Behavioral Therapy for Insomnia Industry Drivers
  3. 2.3 Cognitive Behavioral Therapy for Insomnia Industry Opportunities and Challenges
  4. 2.4 Cognitive Behavioral Therapy for Insomnia Industry Restraints
3 Cognitive Behavioral Therapy for Insomnia Market by Company
  1. 3.1 Global Cognitive Behavioral Therapy for Insomnia Company Revenue Ranking in 2025
  2. 3.2 Global Cognitive Behavioral Therapy for Insomnia Revenue by Company (2021-2026)
  3. 3.3 Global Cognitive Behavioral Therapy for Insomnia Company Ranking (2024-2026)
  4. 3.4 Global Cognitive Behavioral Therapy for Insomnia Company Manufacturing Base and Headquarters
  5. 3.5 Global Cognitive Behavioral Therapy for Insomnia Company Product Type and Application
  6. 3.6 Global Cognitive Behavioral Therapy for Insomnia Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Cognitive Behavioral Therapy for Insomnia Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Cognitive Behavioral Therapy for Insomnia Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Cognitive Behavioral Therapy for Insomnia Market by Type
  1. 4.1 Cognitive Behavioral Therapy for Insomnia Type Introduction
  2. 4.1.1 Non Pharmacological Therapy
  3. 4.1.2 Pharmacological Therapy
  4. 4.2 Global Cognitive Behavioral Therapy for Insomnia Sales Value by Type
  5. 4.2.1 Global Cognitive Behavioral Therapy for Insomnia Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Cognitive Behavioral Therapy for Insomnia Sales Value by Type (2021-2032)
  7. 4.2.3 Global Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type (2021-2032)
5 Cognitive Behavioral Therapy for Insomnia Market by Application
  1. 5.1 Cognitive Behavioral Therapy for Insomnia Application Introduction
  2. 5.1.1 Mental Health Services
  3. 5.1.2 Sleep Clinics
  4. 5.1.3 Pharmaceutical Industry
  5. 5.1.4 Sleep-related Devices and Technology
  6. 5.2 Global Cognitive Behavioral Therapy for Insomnia Sales Value by Application
  7. 5.2.1 Global Cognitive Behavioral Therapy for Insomnia Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Cognitive Behavioral Therapy for Insomnia Sales Value by Application (2021-2032)
  9. 5.2.3 Global Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application (2021-2032)
6 Cognitive Behavioral Therapy for Insomnia Regional Value Analysis
  1. 6.1 Global Cognitive Behavioral Therapy for Insomnia Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cognitive Behavioral Therapy for Insomnia Sales Value by Region (2021-2032)
  3. 6.2.1 Global Cognitive Behavioral Therapy for Insomnia Sales Value by Region: 2021-2026
  4. 6.2.2 Global Cognitive Behavioral Therapy for Insomnia Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cognitive Behavioral Therapy for Insomnia Sales Value (2021-2032)
  7. 6.3.2 North America Cognitive Behavioral Therapy for Insomnia Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Cognitive Behavioral Therapy for Insomnia Sales Value (2021-2032)
  10. 6.4.2 Europe Cognitive Behavioral Therapy for Insomnia Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Cognitive Behavioral Therapy for Insomnia Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Cognitive Behavioral Therapy for Insomnia Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Cognitive Behavioral Therapy for Insomnia Sales Value (2021-2032)
  16. 6.6.2 South America Cognitive Behavioral Therapy for Insomnia Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Cognitive Behavioral Therapy for Insomnia Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Cognitive Behavioral Therapy for Insomnia Sales Value Share by Country, 2025 VS 2032
7 Cognitive Behavioral Therapy for Insomnia Country-level Value Analysis
  1. 7.1 Global Cognitive Behavioral Therapy for Insomnia Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cognitive Behavioral Therapy for Insomnia Sales Value by Country (2021-2032)
  3. 7.2.1 Global Cognitive Behavioral Therapy for Insomnia Sales Value by Country (2021-2026)
  4. 7.2.2 Global Cognitive Behavioral Therapy for Insomnia Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Cognitive Behavioral Therapy for Insomnia Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Cognitive Behavioral Therapy for Insomnia Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Cognitive Behavioral Therapy for Insomnia Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 MINERVA NEUROSCIENCES INC
  2. 8.1.1 MINERVA NEUROSCIENCES INC Company Information
  3. 8.1.2 MINERVA NEUROSCIENCES INC Business Overview
  4. 8.1.3 MINERVA NEUROSCIENCES INC Cognitive Behavioral Therapy for Insomnia Revenue and Gross Margin (2021-2026)
  5. 8.1.4 MINERVA NEUROSCIENCES INC Cognitive Behavioral Therapy for Insomnia Product Portfolio
  6. 8.1.5 MINERVA NEUROSCIENCES INC Recent Developments
  7. 8.2 CURRAX PHARMACEUTICALS LLC
  8. 8.2.1 CURRAX PHARMACEUTICALS LLC Company Information
  9. 8.2.2 CURRAX PHARMACEUTICALS LLC Business Overview
  10. 8.2.3 CURRAX PHARMACEUTICALS LLC Cognitive Behavioral Therapy for Insomnia Revenue and Gross Margin (2021-2026)
  11. 8.2.4 CURRAX PHARMACEUTICALS LLC Cognitive Behavioral Therapy for Insomnia Product Portfolio
  12. 8.2.5 CURRAX PHARMACEUTICALS LLC Recent Developments
  13. 8.3 Pfizer Inc.
  14. 8.3.1 Pfizer Inc. Company Information
  15. 8.3.2 Pfizer Inc. Business Overview
  16. 8.3.3 Pfizer Inc. Cognitive Behavioral Therapy for Insomnia Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Inc. Cognitive Behavioral Therapy for Insomnia Product Portfolio
  18. 8.3.5 Pfizer Inc. Recent Developments
  19. 8.4 Sanofi
  20. 8.4.1 Sanofi Company Information
  21. 8.4.2 Sanofi Business Overview
  22. 8.4.3 Sanofi Cognitive Behavioral Therapy for Insomnia Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sanofi Cognitive Behavioral Therapy for Insomnia Product Portfolio
  24. 8.4.5 Sanofi Recent Developments
  25. 8.5 zydus cadila
  26. 8.5.1 zydus cadila Company Information
  27. 8.5.2 zydus cadila Business Overview
  28. 8.5.3 zydus cadila Cognitive Behavioral Therapy for Insomnia Revenue and Gross Margin (2021-2026)
  29. 8.5.4 zydus cadila Cognitive Behavioral Therapy for Insomnia Product Portfolio
  30. 8.5.5 zydus cadila Recent Developments
  31. 8.6 Vanda Pharmaceuticals Inc.
  32. 8.6.1 Vanda Pharmaceuticals Inc. Company Information
  33. 8.6.2 Vanda Pharmaceuticals Inc. Business Overview
  34. 8.6.3 Vanda Pharmaceuticals Inc. Cognitive Behavioral Therapy for Insomnia Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Vanda Pharmaceuticals Inc. Cognitive Behavioral Therapy for Insomnia Product Portfolio
  36. 8.6.5 Vanda Pharmaceuticals Inc. Recent Developments
  37. 8.7 EISAI,
  38. 8.7.1 EISAI, Company Information
  39. 8.7.2 EISAI, Business Overview
  40. 8.7.3 EISAI, Cognitive Behavioral Therapy for Insomnia Revenue and Gross Margin (2021-2026)
  41. 8.7.4 EISAI, Cognitive Behavioral Therapy for Insomnia Product Portfolio
  42. 8.7.5 EISAI, Recent Developments
  43. 8.8 merck kgaa
  44. 8.8.1 merck kgaa Company Information
  45. 8.8.2 merck kgaa Business Overview
  46. 8.8.3 merck kgaa Cognitive Behavioral Therapy for Insomnia Revenue and Gross Margin (2021-2026)
  47. 8.8.4 merck kgaa Cognitive Behavioral Therapy for Insomnia Product Portfolio
  48. 8.8.5 merck kgaa Recent Developments
  49. 8.9 darmstadt
  50. 8.9.1 darmstadt Company Information
  51. 8.9.2 darmstadt Business Overview
  52. 8.9.3 darmstadt Cognitive Behavioral Therapy for Insomnia Revenue and Gross Margin (2021-2026)
  53. 8.9.4 darmstadt Cognitive Behavioral Therapy for Insomnia Product Portfolio
  54. 8.9.5 darmstadt Recent Developments
  55. 8.10 germany
  56. 8.10.1 germany Company Information
  57. 8.10.2 germany Business Overview
  58. 8.10.3 germany Cognitive Behavioral Therapy for Insomnia Revenue and Gross Margin (2021-2026)
  59. 8.10.4 germany Cognitive Behavioral Therapy for Insomnia Product Portfolio
  60. 8.10.5 germany Recent Developments
  61. 8.11 VIATRIS INC
  62. 8.11.1 VIATRIS INC Company Information
  63. 8.11.2 VIATRIS INC Business Overview
  64. 8.11.3 VIATRIS INC Cognitive Behavioral Therapy for Insomnia Revenue and Gross Margin (2021-2026)
  65. 8.11.4 VIATRIS INC Cognitive Behavioral Therapy for Insomnia Product Portfolio
  66. 8.11.5 VIATRIS INC Recent Developments
  67. 8.12 Takeda Pharmaceutical Company
  68. 8.12.1 Takeda Pharmaceutical Company Company Information
  69. 8.12.2 Takeda Pharmaceutical Company Business Overview
  70. 8.12.3 Takeda Pharmaceutical Company Cognitive Behavioral Therapy for Insomnia Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Takeda Pharmaceutical Company Cognitive Behavioral Therapy for Insomnia Product Portfolio
  72. 8.12.5 Takeda Pharmaceutical Company Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst